William C. Lumma

3.2k total citations
62 papers, 2.3k citations indexed

About

William C. Lumma is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, William C. Lumma has authored 62 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Organic Chemistry, 26 papers in Molecular Biology and 7 papers in Infectious Diseases. Recurrent topics in William C. Lumma's work include Synthesis and Biological Evaluation (13 papers), Synthesis and Reactions of Organic Compounds (11 papers) and Chemical Synthesis and Analysis (9 papers). William C. Lumma is often cited by papers focused on Synthesis and Biological Evaluation (13 papers), Synthesis and Reactions of Organic Compounds (11 papers) and Chemical Synthesis and Analysis (9 papers). William C. Lumma collaborates with scholars based in United States and Japan. William C. Lumma's co-authors include Elinor H. Cantor, Paul Anderson, Gabor M. Rubanyi, L Botelho, Elena Ho, Susan F. Britcher, Joel R. Huff, Steven D. Young, Terry A. Lyle and Linda S. Payne and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and The Journal of Physical Chemistry.

In The Last Decade

William C. Lumma

60 papers receiving 2.2k citations

Peers

Countries citing papers authored by William C. Lumma

Since Specialization

Citations

This map shows the geographic impact of William C. Lumma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William C. Lumma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William C. Lumma more than expected).

Fields of papers citing papers by William C. Lumma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William C. Lumma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William C. Lumma. The network helps show where William C. Lumma may publish in the future.

Co-authorship network of co-authors of William C. Lumma

This figure shows the co-authorship network connecting the top 25 collaborators of William C. Lumma. A scholar is included among the top collaborators of William C. Lumma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William C. Lumma. William C. Lumma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The synthesis and biological evaluation of a series of potent dual inhibitors of farnesyl and geranyl-Geranyl protein transferases 2002 ·Bioorganic & Medicinal Chemistry Letters ·Thomas J. Tucker, Marc Abrams, Carolyn A. Buser, Joseph P. Davide, Michelle Ellis-Hutchings, Christine Fernandes, W. Wayt Gibbs, Samuel Graham, George D. Hartman, Hans E. Huber, Dongming Liu, Robert B. Lobell, William C. Lumma, R. Robinson, John T. Sisko, Anthony M. Smith	13
2	Anions Modulate the Potency of Geranylgeranyl-Protein Transferase I Inhibitors 2001 ·Journal of Biological Chemistry ·Hans E. Huber, R. Robinson, (unknown), Deborah D. Nahas, Marc Abrams, Carolyn A. Buser, Robert B. Lobell, D Patrick, Neville J. Anthony, Christopher J. Dinsmore, Samuel Graham, George D. Hartman, William C. Lumma, Theresa M. Williams, David Heimbrook	16
3	Design of Novel, Potent, Noncovalent Inhibitors of Thrombin with Nonbasic P-1 Substructures: Rapid Structure−Activity Studies by Solid-Phase Synthesis 1998 ·Journal of Medicinal Chemistry ·William C. Lumma, Keith M. Witherup, Thomas J. Tucker, (unknown), John T. Sisko, Adel M. Naylor-Olsen, Sidney D. Lewis, Bobby J. Lucas, Joseph P. Vacca	63
4	[24] Development of nonnucleoside HIV reverse transcriptase inhibitors 1996 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Thomas J. Tucker, William C. Lumma, Joseph Culberson	11
5	Martinelline and Martinellic Acid, Novel G-Protein Linked Receptor Antagonists from the Tropical Plant Martinella iquitosensis (Bignoniaceae) 1995 ·Journal of the American Chemical Society ·Keith M. Witherup, Richard W. Ransom, Amy C. Graham, (unknown), Michael J. Salvatore, William C. Lumma, Paul Anderson, Steven M. Pitzenberger, Sándor Varga	253
6	Synthesis of a Series of 4-(Arylethynyl)-6-chloro-4-cyclopropyl-3,4-dihydroquinazolin-2(1H)-ones as Novel Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors 1994 ·Journal of Medicinal Chemistry ·Thomas J. Tucker, Terry A. Lyle, (unknown), Susan F. Britcher, Steven D. Young, William M. Sanders, William C. Lumma, Mark E. Goldman, J A O'Brien	54
7	A series of potent HIV-1 protease inhibitors containing a hydroxyethyl secondary amine transition state isostere: synthesis, enzyme inhibition, and antiviral activity 1992 ·Journal of Medicinal Chemistry ·Thomas J. Tucker, William C. Lumma, Linda S. Payne, Jenny Wai, (unknown), Elizabeth A. Giuliani, Paul L. Darke, Jill C. Heimbach, Joan A. Zugay	39
8	Synthesis, cardiac electrophysiology, and .beta.-blocking activity of novel arylpiperazines with potential as class II/III antiarrhythmic agents 1992 ·Journal of Medicinal Chemistry ·(unknown), (unknown), William C. Lumma, Robert Gomez, (unknown), (unknown), Thomas M. Argentieri, (unknown)	16
9	Cytoprotective function of nitric oxide: Inactivation of superoxide radicals produced by human leukocytes 1991 ·Biochemical and Biophysical Research Communications ·Gabor M. Rubanyi, Elena Ho, Elinor H. Cantor, William C. Lumma, L Botelho	316
10	Synthesis and biological activity of angiotensin II analog containing a Val-His replacement, Val.psi.[CH(CONH2)HN]His 1991 ·Journal of Medicinal Chemistry ·Raju Mohan, (unknown), Ron Bihovsky, William C. Lumma, Paul Erhardt, Kenneth J. Shaw	18
11	Lack of biological activity of preproendothelin [110–130] in several endothelin assays 1990 ·Life Sciences ·Christina Cade, William C. Lumma, Raju Mohan, Gabor M. Rubanyi, (unknown)	4
12	Cardiotonic agents. 6. Histamine analogs as potential cardiovascular selective H2 agonists 1990 ·Journal of Medicinal Chemistry ·John W. Lampe, (unknown), (unknown), (unknown), Paul Erhardt, William C. Lumma, Stanley S. Greenberg, W. R. Ingebretsen, Dennis C. Marshall, Jay R. Wiggins	6
13	Synthesis and pharmacological studies of N-[4-[2-hydroxy-3-[[2-[4-(1H-imidazol-1-yl)phenoxy]ethyl]amino]propoxy]phenyl]methanesulfonamide, a novel antiarrhythmic agent with class II and class III activities 1990 ·Journal of Medicinal Chemistry ·(unknown), (unknown), William C. Lumma, (unknown), Klaus Nickisch, (unknown), (unknown), (unknown), (unknown)	10
14	Heterocyclic analogs of benzamide antiarrhythmic agents 1989 ·Journal of Medicinal Chemistry ·(unknown), John W. Lampe, William C. Lumma, Paul Erhardt, S.S.M. Wong, Mark Sullivan	3
15	Synthesis and antiarrhythmic activity of novel 3-alkyl-1-[.omega.-[4-[(alkylsulfonyl)amino]phenyl]-.omega.-hydroxyalkyl]-1H-imidazolium salts and related compounds. 2 1987 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), William C. Lumma, (unknown), (unknown), (unknown), Thomas M. Argentieri, Mark Sullivan, Elinor H. Cantor	11
16	Cardiotonic agents. 1. Novel 8-aryl substituted imidazo[1,2-a]- and -[1,5-a]pyridines and imidazo[1,5-a]pyridinones as potential positive inotropic agents 1987 ·Journal of Medicinal Chemistry ·(unknown), Paul Erhardt, William C. Lumma, Jay R. Wiggins, M. Sullivan, David Pang, Elinor H. Cantor	98
17	Rational design of 4-[(methylsulfonyl)amino]benzamides as class III antiarrhythmic agents 1987 ·Journal of Medicinal Chemistry ·William C. Lumma, (unknown), David D. Davey, Thomas M. Argentieri, Robert J. DeVita, Robert Gomez, Vijay Kumar Jain, (unknown), (unknown)	33
18	Piperazinylimidazo[1,2-a]pyrazines with selective affinity for in vitro .alpha.-adrenergic receptor subtypes 1983 ·Journal of Medicinal Chemistry ·William C. Lumma, William C. Randall, Emlen L. Cresson, Joel R. Huff, Richard D. Hartman, (unknown)	40
19	Conformational requirements for histamine H2-receptor inhibitors: a structure-activity study of phenylene analogs related to cimetidine and tiotidine 1983 ·Journal of Medicinal Chemistry ·J. M. HOFFMAN, (unknown), Charles N. Habecker, Brian T. Phillips, William A. Bolhofer, Edward J. Cragoe, Mary Lou Torchiana, William C. Lumma, John J. Baldwin	9
20	Symbiotic approach to drug design: antihypertensive .beta.-adrenergic blocking agents 1979 ·Journal of Medicinal Chemistry ·John J. Baldwin, William C. Lumma, G. F. Lundell, G. S. PONTICELLO, (unknown), Edward L. Engelhardt, Ralph Hirschmann, Charles S. Sweet, Alexander Scriabine	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact